Recently, I-7ab has been found to inhibit the growth of triple-negative breast cancer (TNBC) cells via targeting HDAC3 and promoting p53 acetylation (Yang et al. 2018). This evidence concerns the gene HDAC3 and triple-negative breast carcinoma.